A comprehensive view of moderna inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna to report first quarter 2024 financial results on Thursday, May 2, 2024

Pfizer and BioNTech get temporary reprieve in patent dispute with Moderna, allowing more time for the Patent Trial and Appeal Board to review challenges; Pfizer and BioNTech’s COVID-19 vaccine to remain on the market despite lawsuit

Patent Application Titled 'Variant Strain-Based Coronavirus Vaccines' Published Online (USPTO 20240100151)

Moderna halts construction of planned vaccine manufacturing facility in Kenya due to post-pandemic decrease in COVID-19 vaccine demand; reports losses of over $1.0B to lack of African orders since 2022

Moderna's COVID-19 vaccine, mRNA-1273, proves safe and effective in solid organ transplant recipients in Phase 3b trial; the trial shows that three doses of the vaccine elicited improved neutralizing antibody responses among these high-risk individuals

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count